ClinicalTrials.Veeva

Menu

Early Detection of Lung Cancer With Machine Learning Based on Routine Clinical Investigations

T

The University Clinic of Pulmonary and Allergic Diseases Golnik

Status

Not yet enrolling

Conditions

Adenocarcinoma of Lung; Bronchial Neoplasms; Early Detection of Cancer; Machine Learning

Treatments

Other: Observational

Study type

Observational

Funder types

Other

Identifiers

NCT05907577
3023226

Details and patient eligibility

About

This observational, cross-sectional study in lung cancer patients and lung cancer-free controls aims to develop a machine learning model for early detection of LC based on routine, widely accessible and minimally invasive clinical investigations. The model with adequate predictive performance could later be used in clinical practice as an aid in defining the optimal population and timing for lung cancer screening program.

Enrollment

7,500 estimated patients

Sex

All

Ages

50 to 79 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

All patients:

  • Age ≥ 50 years and < 80 years at the index date of diagnosis (for Cases) or pseudodiagnosis (for Controls).
  • Presence of at least one extended blood analysis, spirometry and DLCO report within the 6 months before the index date.
  • Chest CT scan performed in a non-urgent setting (electively) within the 6 months before the index date (= index CT).
  • Active smokers at the index date or former smokers that ceased smoking within 15 years before the index date.
  • Smoking history ≥ 20 pack-years.

Additional for Cases only: Confirmed histological diagnosis of bronchogenic lung cancer in the time period ≥ 2010 and ≤ 2020.

Additional for Controls only:

  • Absence of lung cancer at all times ≤ 2020, confirmed by chest CT scan at the index date.
  • Documented to live without diagnosis of lung cancer for at least 3 years after the index date.

Extended criteria for the lung cancer prediction subgroup:

In addition to the above stated inclusion criteria, patients in this subgroup have at least one extended blood analysis, spirometry and DLCO report available in the time interval between 3-5 years before the index date.

Trial design

7,500 participants in 2 patient groups

Disease cohort
Description:
Observational, no interventions
Treatment:
Other: Observational
Control cohort
Description:
Observational, no interventions
Treatment:
Other: Observational

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems